共有 50 筆近期內部人交易記錄紀錄，涉及 Medtronic plc (MDT), 包括 12 筆買入 和 29 筆賣出. 內部人買入總額為 $755.34K 內部人賣出總額為 $1.69M.
近期活躍的重要內部人包括 Pieton Thierry, Blomquist Denise L., Kiil Harry Skip. 內部人交易記錄可以揭示公司管理層對股票估值和未來前景的看法.
內部人交易記錄 — MDT
| 日期 |
姓名 |
職位 |
交易類型 |
股數 |
平均價格 |
總價值 |
持股數量 |
| 2026-03-03 |
Pieton Thierry |
EVP & Chief Financial Officer |
RSU 預扣稅 |
2,976 |
$96.71 |
$287.81K |
37,574 |
| 2026-02-20 |
Blomquist Denise L. |
Chief Accounting Officer |
贈與（送出） |
340 |
- |
- |
11,966 |
| 2026-02-19 |
Kiil Harry Skip |
EVP & President Cardiovascular |
期權行權（賣出） |
385 |
$80.00 |
$30.8K |
1,155 |
| 2026-01-29 |
Blomquist Denise L. |
Chief Accounting Officer |
RSU 預扣稅 |
148 |
$101.00 |
$14.95K |
12,306 |
| 2025-12-15 |
Wall Brett A. |
EVP & Pres Neuroscience |
RSU 預扣稅 |
439 |
$99.87 |
$43.84K |
54,749 |
| 2025-12-15 |
Martha Geoffrey |
Chairman and CEO |
RSU 預扣稅 |
1,564 |
$99.87 |
$156.2K |
246,393 |
| 2025-12-15 |
Marinaro Michael |
EVP, Pres Medsurg and Americas |
RSU 預扣稅 |
1,371 |
$99.87 |
$136.92K |
50,818 |
| 2025-12-05 |
Kiil Harry Skip |
EVP & President Cardiovascular |
RSU 預扣稅 |
1,702 |
$101.36 |
$172.51K |
34,177 |
| 2025-11-20 |
Blomquist Denise L. |
Chief Accounting Officer |
贈與（送出） |
170 |
- |
- |
12,357 |
| 2025-11-19 |
Smith Gregory L |
EVP Global Ops & Supply Chain |
知情賣出 |
500 |
$102.08 |
$51.04K |
46,016 |
| 2025-09-03 |
Kiil Harry Skip |
EVP & President Cardiovascular |
知情賣出 |
200 |
$91.59 |
$18.32K |
35,615 |
| 2025-08-25 |
Jellison William R |
Director |
知情買入 |
2,500 |
$92.37 |
$230.93K |
5,000 |
| 2025-08-22 |
Jellison William R |
Director |
知情買入 |
2,500 |
$92.73 |
$231.83K |
2,500 |
| 2025-08-20 |
Marinaro Michael |
EVP, Pres Medsurg and Americas |
RSU 預扣稅 |
1,052 |
$93.22 |
$98.07K |
51,939 |
| 2025-08-19 |
Jellison William R |
Director |
未知 |
- |
- |
- |
- |
| 2025-08-19 |
Groetelaars John P |
Director |
未知 |
- |
- |
- |
- |
| 2025-08-01 |
Wall Brett A. |
EVP & Pres Neuroscience |
期權行權（賣出） |
15,249 |
- |
- |
- |
| 2025-08-01 |
Smith Gregory L |
EVP Global Ops & Supply Chain |
期權行權（賣出） |
11,328 |
- |
- |
- |
| 2025-08-01 |
Martha Geoffrey |
Chairman and CEO |
期權行權（賣出） |
57,724 |
- |
- |
- |
| 2025-08-01 |
Kiil Harry Skip |
EVP & President Cardiovascular |
期權行權（賣出） |
10,457 |
- |
- |
- |
| 2025-08-01 |
Marinaro Michael |
EVP, Pres Medsurg and Americas |
期權行權（賣出） |
3,126 |
$78.00 |
$243.83K |
- |
| 2025-08-01 |
Walter Matthew R. |
SVP, Chief HR Officer |
期權行權（賣出） |
2,179 |
- |
- |
- |
| 2025-08-01 |
Blomquist Denise L. |
Chief Accounting Officer |
期權行權（賣出） |
58 |
- |
- |
- |
| 2025-07-31 |
Smith Gregory L |
EVP Global Ops & Supply Chain |
RSU 預扣稅 |
1,630 |
$90.24 |
$147.09K |
71,743 |
| 2025-07-29 |
Corona Gary Louis |
Interim CFO |
處置 |
1,540 |
$80.00 |
$123.2K |
- |
| 2025-07-29 |
Kiil Harry Skip |
EVP & President Cardiovascular |
未知 |
1,540 |
$80.00 |
$123.2K |
- |
| 2025-07-28 |
Wall Brett A. |
EVP & Pres Neuroscience |
限制性股票授予 (RSU) |
24,465 |
- |
- |
24,465 |
| 2025-07-28 |
Smith Gregory L |
EVP Global Ops & Supply Chain |
限制性股票授予 (RSU) |
24,465 |
- |
- |
24,465 |
| 2025-07-28 |
Martha Geoffrey |
Chairman and CEO |
限制性股票授予 (RSU) |
93,781 |
- |
- |
93,781 |
| 2025-07-28 |
Kiil Harry Skip |
EVP & President Cardiovascular |
限制性股票授予 (RSU) |
19,028 |
- |
- |
19,028 |
| 2025-07-28 |
Quinn Michelle |
EVP, Gc and Secretary |
限制性股票授予 (RSU) |
5,437 |
- |
- |
5,437 |
| 2025-07-28 |
Marinaro Michael |
EVP, Pres Medsurg and Americas |
限制性股票授予 (RSU) |
24,465 |
- |
- |
24,465 |
| 2025-07-28 |
Walter Matthew R. |
SVP, Chief HR Officer |
限制性股票授予 (RSU) |
10,874 |
- |
- |
10,874 |
| 2025-07-28 |
Pieton Thierry |
EVP & Chief Financial Officer |
限制性股票授予 (RSU) |
21,747 |
- |
- |
21,747 |
| 2025-07-28 |
Blomquist Denise L. |
Chief Accounting Officer |
限制性股票授予 (RSU) |
1,278 |
$91.97 |
$117.54K |
1,278 |
| 2025-07-21 |
Quinn Michelle |
EVP, Gc and Secretary |
未知 |
- |
- |
- |
- |
| 2025-06-18 |
Lee Joon Sup |
Director |
未知 |
- |
- |
- |
- |
| 2025-06-03 |
Blomquist Denise L. |
Chief Accounting Officer |
贈與（送出） |
310 |
- |
- |
10,143 |
| 2025-05-21 |
Kiil Harry Skip |
EVP & President Cardiovascular |
未知 |
15,378 |
- |
- |
- |
| 2025-05-02 |
Walter Matthew R. |
SVP, Chief HR Officer |
RSU 預扣稅 |
34 |
$84.85 |
$2.88K |
26,054 |
| 2025-04-29 |
Arnold Craig |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
40,216 |
| 2025-04-29 |
Hogan Randall J |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
47,029 |
| 2025-04-29 |
Donnelly Scott C |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
21,630 |
| 2025-04-29 |
Powell Kendall J |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
48,622 |
| 2025-04-29 |
Fonseca Lidia |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
5,675 |
| 2025-04-29 |
Lofton Kevin E |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
8,171 |
| 2025-04-29 |
Nabel Elizabeth G |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
17,615 |
| 2025-04-29 |
Goldsmith Andrea Jo |
Director |
RSU 預扣稅 |
216 |
$84.60 |
$18.27K |
10,247 |
| 2025-04-29 |
Lewis Gregory P |
Director |
RSU 預扣稅 |
181 |
$84.60 |
$15.31K |
3,785 |
| 2025-04-28 |
Arnold Craig |
Director |
限制性股票授予 (RSU) |
2,083 |
$84.04 |
$175.06K |
40,432 |
■ 知情交易 — 公開市場買賣（最具參考價值）
■ 非知情買入 — 獎勵、期權行權、轉換
■ 非知情賣出 — 稅務代扣、歸屬出售
■ 中性 — 禮贈、信託、到期
